Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-01-06 @ 10:52 PM
Study NCT ID:
NCT02993094
Status:
TERMINATED
Last Update Posted:
2020-11-30
First Post:
2016-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-15
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-04
First Submit QC Date:
None
Study First Post Date:
2016-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-26
Last Update Post Date:
2020-11-30
Last Update Post Date Type:
ACTUAL